| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||







From the * Life Science Research Laboratory,
Technical Research Institute, Corporate Manufacturing, Technology and Research
Division, Toppan Printing Co, Ltd, Tokyo, Japan; the
Department of Urology, Graduate School of
Medicine, Osaka University, Osaka, Japan; the
Cell Resource Center for Biomedical Research,
Institute of Development, Aging and Cancer, Tohoku University, Sendai, Japan;
the
Research Collaboration Center on Emerging
and Re-emerging Infections, Research Institute for Microbial Diseases, Osaka
University, Osaka, Japan; and the || Faculty of
Pharmaceutical Sciences, Nagasaki International University, Nagasaki,
Japan.
| Correspondence to: Dr Hiromitsu Tanaka, Faculty of Pharmaceutical Sciences, Nagasaki International University, Sasebo, Nagasaki, 859-3298, Japan (e-mail: h-tanaka{at}niu.ac.jp). |
To investigate the possible association between variations in the
PRDM9 (MEISETZ) gene and impaired spermatogenesis in humans,
we screened for mutations in the human PRDM9 gene using DNA from 217
sterile male patients and 162 provenfertile male volunteers. Two
single-nucleotide polymorphisms (SNPs), 17353G>T (Gly433Val) and
18109C>G (Thr685Arg), were identified, as well as an intronic SNP,
15549G>T. These SNPs were identified in the heterozygous state in separate
patients who demonstrated azoospermia. Neither variant was identified in
fertile subjects. Our results suggest that mutations in PRDM9 may
cause idiopathic infertility in human males.
Key words: Sperm, male infertility, genome, SNPs, spermatogenesis
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |